MedTrace Logo

26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Sleep Efficiency in Healthy Adults

NCT03559361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-06-18

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of EPA- and DHA-enriched omega-3 polyunsaturated fatty acid dietary supplements on a number of objective sleep measures (collected from Activity watches) and subjective sleep measures (collected from the Leeds Sleep Evaluation Questionnaire) before and after 26 weeks of supplementation

Conditions

  • Sleep

Interventions

DIETARY_SUPPLEMENT

EPA-rich

6 months omega 3 supplementation

DIETARY_SUPPLEMENT

DHA-rich

6 months omega 3 supplementation

DIETARY_SUPPLEMENT

Olive oil Placebo

6 months placebo supplementation

Sponsors & Collaborators

  • BASF

    collaborator INDUSTRY

  • Northumbria University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2018-02-20
Completion
2018-02-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03559361 on ClinicalTrials.gov